INKT
Price
$10.97
Change
-$0.34 (-3.01%)
Updated
Nov 19, 04:18 PM (EDT)
Capitalization
50.88M
Intraday BUY SELL Signals
PHVS
Price
$24.59
Change
+$0.62 (+2.59%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.6B
145 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INKT vs PHVS

Header iconINKT vs PHVS Comparison
Open Charts INKT vs PHVSBanner chart's image
MiNK Therapeutics
Price$10.97
Change-$0.34 (-3.01%)
Volume$100
Capitalization50.88M
Pharvaris
Price$24.59
Change+$0.62 (+2.59%)
Volume$14.76K
Capitalization1.6B
INKT vs PHVS Comparison Chart in %
INKT
Daily Signal:
Gain/Loss:
PHVS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
INKT vs. PHVS commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INKT is a Hold and PHVS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (INKT: $10.84 vs. PHVS: $24.59)
Brand notoriety: INKT and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INKT: 43% vs. PHVS: 276%
Market capitalization -- INKT: $50.88M vs. PHVS: $1.6B
INKT [@Biotechnology] is valued at $50.88M. PHVS’s [@Biotechnology] market capitalization is $1.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INKT’s FA Score shows that 0 FA rating(s) are green whilePHVS’s FA Score has 1 green FA rating(s).

  • INKT’s FA Score: 0 green, 5 red.
  • PHVS’s FA Score: 1 green, 4 red.
According to our system of comparison, PHVS is a better buy in the long-term than INKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INKT’s TA Score shows that 4 TA indicator(s) are bullish while PHVS’s TA Score has 6 bullish TA indicator(s).

  • INKT’s TA Score: 4 bullish, 6 bearish.
  • PHVS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PHVS is a better buy in the short-term than INKT.

Price Growth

INKT (@Biotechnology) experienced а -20.76% price change this week, while PHVS (@Biotechnology) price change was -4.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

PHVS is expected to report earnings on Apr 14, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($1.6B) has a higher market cap than INKT($50.9M). INKT YTD gains are higher at: 55.546 vs. PHVS (28.299). INKT has higher annual earnings (EBITDA): -9.92M vs. PHVS (-165.21M). PHVS has more cash in the bank: 200M vs. INKT (1.68M). PHVS has less debt than INKT: PHVS (634K) vs INKT (5.51M). INKT (0) and PHVS (0) have equivalent revenues.
INKTPHVSINKT / PHVS
Capitalization50.9M1.6B3%
EBITDA-9.92M-165.21M6%
Gain YTD55.54628.299196%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.68M200M1%
Total Debt5.51M634K868%
TECHNICAL ANALYSIS
Technical Analysis
INKTPHVS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
INKT
Daily Signal:
Gain/Loss:
PHVS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OSCNX21.730.10
+0.46%
Invesco Main Street Small Cap R
EGFIX46.06N/A
N/A
Edgewood Growth Instl
SVYAX11.85N/A
N/A
SEI US Managed Volatility A (SIIT)
LOGBX37.54N/A
N/A
Scharf Multi-Asset Opportunity Retail
ARYMX13.60N/A
N/A
American Century Global Real Estate A

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with RAIN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-4.16%
RAIN - INKT
43%
Loosely correlated
+1.57%
HYPD - INKT
34%
Loosely correlated
-5.13%
PHVS - INKT
34%
Loosely correlated
+2.61%
TERN - INKT
30%
Poorly correlated
-1.60%
ORMP - INKT
29%
Poorly correlated
+0.80%
More

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with NUVL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
+2.61%
NUVL - PHVS
40%
Loosely correlated
+2.71%
MGTX - PHVS
36%
Loosely correlated
-2.19%
INKT - PHVS
34%
Loosely correlated
-4.16%
SNDX - PHVS
33%
Loosely correlated
-2.22%
ROIV - PHVS
33%
Loosely correlated
-0.88%
More